In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
"I am really trying to change the traditional CFO landscape," said Mr. Firdausi during an interview with "Becker's Healthcare Podcast." "Having the PBM background, having the payer background and now ...
Opinion
2dOpinion
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
Hollywood-based AIDS Healthcare Foundation has won a $10.3 million arbitration award in a dispute with a pharmacy benefit ...
As PBM services have traditionally been dominated by large companies such as CVS Caremark, Express Scripts and OptumRx, health systems are starting to create alternatives. Here are four more things to ...
A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback